Plancorp LLC Portfolio holdings
Plancorp is a financial planning and wealth management firm that Jeff Buckner founded in St. Louis in 1983, working from his home office. He started it when brokers dominated financial planning and mostly used it to sell products, aiming instead to offer independent planning. Plancorp also manages company retirement plans and handles planning and investing for charities, schools, foundations and endowments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WEC Energy
WEC
|
+$842K |
| 2 |
Wells Fargo
WFC
|
+$400K |
| 3 |
Wheaton Precious Metals
WPM
|
+$389K |
| 4 |
Williams Companies
WMB
|
+$365K |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$305K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$1.35M |
| 2 |
Gilead Sciences
GILD
|
+$1.12M |
| 3 |
PepsiCo
PEP
|
+$1.11M |
| 4 |
AbbVie
ABBV
|
+$979K |
| 5 |
Abbott
ABT
|
+$941K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.5% |
| 2 | Industrials | 17.33% |
| 3 | Financials | 9.24% |
| 4 | Energy | 6.09% |
| 5 | Consumer Staples | 6.08% |
Similar funds
Plancorp LLC's Q2 2019 Portfolio in Review
As of Q2 2019, Plancorp LLC held 183 positions worth $253M, down 4.4% from $264M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Plancorp LLC withdrew a net $13.7M in Q2 2019, closing 14 positions and reducing 76 holdings. Its most notable exit was Gilead Sciences, an estimated $1.12M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, up from 36% a quarter earlier, followed by Industrials and Financials.
Against the trend, Plancorp LLC opened a new position in State Street SPDR Dow Jones Industrial Average ETF Trust worth $275K.
- Plancorp LLC's largest Q2 2019 buy was State Street SPDR Dow Jones Industrial Average ETF Trust: 1,033 shares worth $275K.
- Plancorp LLC added most to WEC Energy in Q2 2019, an estimated $842K increase.
- Plancorp LLC's biggest Q2 2019 reduction was Amgen, cutting an estimated $1.35M.
- Plancorp LLC fully exited Gilead Sciences in Q2 2019, selling an estimated $1.12M.
- Plancorp LLC's ten largest holdings make up 46% of its $253M portfolio in Q2 2019.
- Plancorp LLC opened 8 new positions and closed 14 in Q2 2019.
- Plancorp LLC's portfolio value fell 4.4% quarter-over-quarter to $253M.
Based on Plancorp LLC's 13F filing for Q2 2019, filed 13 Aug 2019.